<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 21 Oct 2026 08:21:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  SCHEDULE 13D/A  InMode Ltd.                            Filed by: Mizrahy Moshe</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++InMode+Ltd.++++++++++++++++++++++++++++Filed+by%3A+Mizrahy+Moshe/27213550.html</link>
   <description>si-local-file:///var/storage/secattach/20261021/27213550.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++InMode+Ltd.++++++++++++++++++++++++++++Filed+by%3A+Mizrahy+Moshe/27213550.html</guid>
   <pubDate>Wed, 21 Oct 2026 08:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	  </item>
  <item>
   <title>Steel Partners Holdings L.P. Issues Open Letter to All InMode Stakeholders and Sets October 30, 2026 Expiration for Its $16.75 Per Share All-Cash Offer</title>
   <link>http://www.streetinsider.com/Press+Releases/Steel+Partners+Holdings+L.P.+Issues+Open+Letter+to+All+InMode+Stakeholders+and+Sets+October+30%2C+2026+Expiration+for+Its+%2416.75+Per+Share+All-Cash+Offer/27200898.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;After More Than Three Months, the Company Has Refused to Engage on Steel’s Proposal &lt;/i&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Steel Believes Directors Breached Their Fiduciary Duties by Demanding Dismissal of Claims Against Them in Exchange for Diligence &lt;/i&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Steel’s Offer Delivers Certain Cash at a Premium or Shareholders Can Remain Invested in InMode&lt;/i&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Absent Meaningful Engagement, Steel Will Hold the Entrenched Board Accountable &lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
Steel Partners Holdings L.P. (together with its affiliates, “Steel”), a significant, long-standing shareholder of InMode Ltd. (“InMode” or the “Company”) (Nasdaq: INMD), today issued an open letter to all InMode stakeholders. The full text</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Steel+Partners+Holdings+L.P.+Issues+Open+Letter+to+All+InMode+Stakeholders+and+Sets+October+30%2C+2026+Expiration+for+Its+%2416.75+Per+Share+All-Cash+Offer/27200898.html</guid>
   <pubDate>Mon, 19 Oct 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	  </item>
  <item>
   <title>Steel Partners Holdings L.P. Issues Open Letter to All InMode Stakeholders and Sets October 30, 2026 Expiration for Its $16.75 Per Share All-Cash Offer</title>
   <link>http://www.streetinsider.com/Business+Wire/Steel+Partners+Holdings+L.P.+Issues+Open+Letter+to+All+InMode+Stakeholders+and+Sets+October+30%2C+2026+Expiration+for+Its+%2416.75+Per+Share+All-Cash+Offer/27200898.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;After More Than Three Months, the Company Has Refused to Engage on Steel’s Proposal &lt;/i&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Steel Believes Directors Breached Their Fiduciary Duties by Demanding Dismissal of Claims Against Them in Exchange for Diligence &lt;/i&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Steel’s Offer Delivers Certain Cash at a Premium or Shareholders Can Remain Invested in InMode&lt;/i&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Absent Meaningful Engagement, Steel Will Hold the Entrenched Board Accountable &lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
Steel Partners Holdings L.P. (together with its affiliates, “Steel”), a significant, long-standing shareholder of InMode Ltd. (“InMode” or the “Company”) (Nasdaq: INMD), today issued an open letter to all InMode stakeholders. The full text</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Steel+Partners+Holdings+L.P.+Issues+Open+Letter+to+All+InMode+Stakeholders+and+Sets+October+30%2C+2026+Expiration+for+Its+%2416.75+Per+Share+All-Cash+Offer/27200898.html</guid>
   <pubDate>Mon, 19 Oct 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	  </item>
  <item>
   <title>InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M</title>
   <link>http://www.streetinsider.com/Press+Releases/InMode+to+Report+Third+Quarter+2026+Financial+Results+on+November+11%2C+2026%2C+Expects+Third+Quarter+Revenue+of+%2491.8+Million+to+%2492.0+Million%2C+Reiterates+FY+2026+Revenue+Guidance+Between+%24365M-%24375M/27176834.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
                &lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;YOKNEAM, &lt;location value=&quot;LC/il&quot; idsrc=&quot;xmltag.org&quot; &gt;Israel&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Oct. 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;NASDAQ-NMS:INMD&quot; idsrc=&quot;xmltag.org&quot; &gt;InMode Ltd.&lt;/span&gt;&lt;/b&gt; (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third quarter of 2026 before the Nasdaq market opens on Wednesday, November 11, 2026.&lt;/p&gt;
                &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
              </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/InMode+to+Report+Third+Quarter+2026+Financial+Results+on+November+11%2C+2026%2C+Expects+Third+Quarter+Revenue+of+%2491.8+Million+to+%2492.0+Million%2C+Reiterates+FY+2026+Revenue+Guidance+Between+%24365M-%24375M/27176834.html</guid>
   <pubDate>Tue, 13 Oct 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	  </item>
  <item>
   <title>InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M</title>
   <link>http://www.streetinsider.com/PRNewswire/InMode+to+Report+Third+Quarter+2026+Financial+Results+on+November+11%2C+2026%2C+Expects+Third+Quarter+Revenue+of+%2491.8+Million+to+%2492.0+Million%2C+Reiterates+FY+2026+Revenue+Guidance+Between+%24365M-%24375M/27176834.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
                &lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;YOKNEAM, &lt;location value=&quot;LC/il&quot; idsrc=&quot;xmltag.org&quot; &gt;Israel&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Oct. 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&lt;span value=&quot;NASDAQ-NMS:INMD&quot; idsrc=&quot;xmltag.org&quot; &gt;InMode Ltd.&lt;/span&gt;&lt;/b&gt; (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third quarter of 2026 before the Nasdaq market opens on Wednesday, November 11, 2026.&lt;/p&gt;
                &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
              </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/InMode+to+Report+Third+Quarter+2026+Financial+Results+on+November+11%2C+2026%2C+Expects+Third+Quarter+Revenue+of+%2491.8+Million+to+%2492.0+Million%2C+Reiterates+FY+2026+Revenue+Guidance+Between+%24365M-%24375M/27176834.html</guid>
   <pubDate>Tue, 13 Oct 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	  </item>
  <item>
   <title>Form  6-K        InMode Ltd.               For: Sep 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Sep+16/27067278.html</link>
   <description>si-local-file:///var/storage/secattach/20260916/27067278.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Sep+16/27067278.html</guid>
   <pubDate>Wed, 16 Sep 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	  </item>
  <item>
   <title>Form  6-K        InMode Ltd.               For: Aug 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+11/26906307.html</link>
   <description>si-local-file:///var/storage/secattach/20260811/26906307.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+11/26906307.html</guid>
   <pubDate>Tue, 11 Aug 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>Form  6-K        InMode Ltd.               For: Aug 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+11/26906307.html</link>
   <description>si-local-file:///var/storage/secattach/20260811/26906307.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+11/26906307.html</guid>
   <pubDate>Tue, 11 Aug 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13D/A  InMode Ltd.                            Filed by: Mizrahy Moshe</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++InMode+Ltd.++++++++++++++++++++++++++++Filed+by%3A+Mizrahy+Moshe/26876323.html</link>
   <description>si-local-file:///var/storage/secattach/20260805/26876323.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++InMode+Ltd.++++++++++++++++++++++++++++Filed+by%3A+Mizrahy+Moshe/26876323.html</guid>
   <pubDate>Wed, 05 Aug 2026 18:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13D/A  InMode Ltd.                            Filed by: Mizrahy Moshe</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++InMode+Ltd.++++++++++++++++++++++++++++Filed+by%3A+Mizrahy+Moshe/26876323.html</link>
   <description>si-local-file:///var/storage/secattach/20260805/26876323.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++InMode+Ltd.++++++++++++++++++++++++++++Filed+by%3A+Mizrahy+Moshe/26876323.html</guid>
   <pubDate>Wed, 05 Aug 2026 18:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>Form  4          InMode Ltd.               For: Aug 04  Filed by: Itzkovich Moshe</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+04++Filed+by%3A+Itzkovich+Moshe/26873722.html</link>
   <description>si-local-file:///var/storage/secattach/20260805/26873722.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+04++Filed+by%3A+Itzkovich+Moshe/26873722.html</guid>
   <pubDate>Wed, 05 Aug 2026 16:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>Form  4          InMode Ltd.               For: Aug 04  Filed by: Itzkovich Moshe</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+04++Filed+by%3A+Itzkovich+Moshe/26873722.html</link>
   <description>si-local-file:///var/storage/secattach/20260805/26873722.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+04++Filed+by%3A+Itzkovich+Moshe/26873722.html</guid>
   <pubDate>Wed, 05 Aug 2026 16:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>InMode Ltd. (INMD) Tops Q3 EPS by 2c ; Offers Guidance</title>
   <link>http://www.streetinsider.com/Earnings/InMode+Ltd.+%28INMD%29+Tops+Q3+EPS+by+2c+%3B+Offers+Guidance/26870321.html</link>
   <description>&lt;p&gt;InMode Ltd. (NASDAQ: INMD) reported Q3 EPS of $0.35, $0.02 better than the analyst estimate of $0.33. Revenue for the quarter came in at $95.6 million versus the consensus estimate of $92.64 million.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;FY 2026 Outlook:-&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Revenues between $365 million and $375 million vs consensus $370.3 million.&lt;br /&gt;Non-GAAP earnings per diluted share between $1.29 and $1.34 vs consensus $1.32.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on InMode Ltd. (INMD) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=INMD&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/InMode+Ltd.+%28INMD%29+Tops+Q3+EPS+by+2c+%3B+Offers+Guidance/26870321.html</guid>
   <pubDate>Wed, 05 Aug 2026 07:31:01 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	  </item>
  <item>
   <title>Form  6-K        InMode Ltd.               For: Aug 05</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+05/26870016.html</link>
   <description>si-local-file:///var/storage/secattach/20260805/26870016.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+05/26870016.html</guid>
   <pubDate>Wed, 05 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>Form  6-K        InMode Ltd.               For: Aug 05</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+05/26870016.html</link>
   <description>si-local-file:///var/storage/secattach/20260805/26870016.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Aug+05/26870016.html</guid>
   <pubDate>Wed, 05 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/InMode+Reports+Second+Quarter+2026+Financial+Results%3A+Quarterly+GAAP+Revenues+of+%2495.6+Million%2C+Consistent+with+the+Second+Quarter+of+2025/26869997.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;YOKNEAM, &lt;location value=&quot;LC/il&quot; idsrc=&quot;xmltag.org&quot; &gt;Israel&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 5, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ --&lt;b&gt; &lt;span value=&quot;NASDAQ-NMS:INMD&quot; idsrc=&quot;xmltag.org&quot; &gt;InMode Ltd.&lt;/span&gt; &lt;/b&gt;(Nasdaq: INMD)&lt;b&gt; (&quot;&lt;span value=&quot;NASDAQ-NMS:INMD&quot; idsrc=&quot;xmltag.org&quot; &gt;InMode&lt;/span&gt;&quot;)&lt;/b&gt;, a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter of 2026.&lt;/p&gt;
&lt;div id=&quot;prni_dvprnejpg59aeleft&quot; dir=&quot;ltr&quot; style=&quot;width: 100%; text-align: left;&quot;&gt;&lt;img id=&quot;prnejpg59aeleft&quot; style=&quot;width: 400px; height: 223px;&quot; title=&quot;InMode Logo&quot; src=&quot;https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg&quot; alt=&quot;InMode Logo&quot; align=&quot;middle&quot; /&gt;&lt;/div&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;Second Quarter 2026 Highlights:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Quarterly GAAP revenues of &lt;money&gt;$95.6 million&lt;/money&gt;, consistent with the second quarter of 2025.&lt;/li&gt;&lt;li&gt;Quarterly revenues from consumables and service of &lt;money&gt;$22.3 million&lt;/money&gt;, an increase of 13% compared to the second quarter of 2025.&lt;/li&gt;&lt;li&gt;GAAP operating income of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/InMode+Reports+Second+Quarter+2026+Financial+Results%3A+Quarterly+GAAP+Revenues+of+%2495.6+Million%2C+Consistent+with+the+Second+Quarter+of+2025/26869997.html</guid>
   <pubDate>Wed, 05 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025</title>
   <link>http://www.streetinsider.com/PRNewswire/InMode+Reports+Second+Quarter+2026+Financial+Results%3A+Quarterly+GAAP+Revenues+of+%2495.6+Million%2C+Consistent+with+the+Second+Quarter+of+2025/26869997.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;YOKNEAM, &lt;location value=&quot;LC/il&quot; idsrc=&quot;xmltag.org&quot; &gt;Israel&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 5, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ --&lt;b&gt; &lt;span value=&quot;NASDAQ-NMS:INMD&quot; idsrc=&quot;xmltag.org&quot; &gt;InMode Ltd.&lt;/span&gt; &lt;/b&gt;(Nasdaq: INMD)&lt;b&gt; (&quot;&lt;span value=&quot;NASDAQ-NMS:INMD&quot; idsrc=&quot;xmltag.org&quot; &gt;InMode&lt;/span&gt;&quot;)&lt;/b&gt;, a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter of 2026.&lt;/p&gt;
&lt;div id=&quot;prni_dvprnejpg59aeleft&quot; dir=&quot;ltr&quot; style=&quot;width: 100%; text-align: left;&quot;&gt;&lt;img id=&quot;prnejpg59aeleft&quot; style=&quot;width: 400px; height: 223px;&quot; title=&quot;InMode Logo&quot; src=&quot;https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg&quot; alt=&quot;InMode Logo&quot; align=&quot;middle&quot; /&gt;&lt;/div&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;Second Quarter 2026 Highlights:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Quarterly GAAP revenues of &lt;money&gt;$95.6 million&lt;/money&gt;, consistent with the second quarter of 2025.&lt;/li&gt;&lt;li&gt;Quarterly revenues from consumables and service of &lt;money&gt;$22.3 million&lt;/money&gt;, an increase of 13% compared to the second quarter of 2025.&lt;/li&gt;&lt;li&gt;GAAP operating income of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/InMode+Reports+Second+Quarter+2026+Financial+Results%3A+Quarterly+GAAP+Revenues+of+%2495.6+Million%2C+Consistent+with+the+Second+Quarter+of+2025/26869997.html</guid>
   <pubDate>Wed, 05 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025</title>
   <link>http://www.streetinsider.com/Press+Releases/InMode+Reports+Second+Quarter+2026+Financial+Results%3A+Quarterly+GAAP+Revenues+of+%2495.6+Million%2C+Consistent+with+the+Second+Quarter+of+2025/26869997.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;YOKNEAM, &lt;location value=&quot;LC/il&quot; idsrc=&quot;xmltag.org&quot; &gt;Israel&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 5, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ --&lt;b&gt; &lt;span value=&quot;NASDAQ-NMS:INMD&quot; idsrc=&quot;xmltag.org&quot; &gt;InMode Ltd.&lt;/span&gt; &lt;/b&gt;(Nasdaq: INMD)&lt;b&gt; (&quot;&lt;span value=&quot;NASDAQ-NMS:INMD&quot; idsrc=&quot;xmltag.org&quot; &gt;InMode&lt;/span&gt;&quot;)&lt;/b&gt;, a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter of 2026.&lt;/p&gt;
&lt;div id=&quot;prni_dvprnejpg59aeleft&quot; dir=&quot;ltr&quot; style=&quot;width: 100%; text-align: left;&quot;&gt;&lt;img id=&quot;prnejpg59aeleft&quot; style=&quot;width: 400px; height: 223px;&quot; title=&quot;InMode Logo&quot; src=&quot;https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg&quot; alt=&quot;InMode Logo&quot; align=&quot;middle&quot; /&gt;&lt;/div&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;Second Quarter 2026 Highlights:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Quarterly GAAP revenues of &lt;money&gt;$95.6 million&lt;/money&gt;, consistent with the second quarter of 2025.&lt;/li&gt;&lt;li&gt;Quarterly revenues from consumables and service of &lt;money&gt;$22.3 million&lt;/money&gt;, an increase of 13% compared to the second quarter of 2025.&lt;/li&gt;&lt;li&gt;GAAP operating income of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/InMode+Reports+Second+Quarter+2026+Financial+Results%3A+Quarterly+GAAP+Revenues+of+%2495.6+Million%2C+Consistent+with+the+Second+Quarter+of+2025/26869997.html</guid>
   <pubDate>Wed, 05 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025</title>
   <link>http://www.streetinsider.com/PRNewswire/InMode+Reports+Second+Quarter+2026+Financial+Results%3A+Quarterly+GAAP+Revenues+of+%2495.6+Million%2C+Consistent+with+the+Second+Quarter+of+2025/26869997.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;YOKNEAM, &lt;location value=&quot;LC/il&quot; idsrc=&quot;xmltag.org&quot; &gt;Israel&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Aug. 5, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ --&lt;b&gt; &lt;span value=&quot;NASDAQ-NMS:INMD&quot; idsrc=&quot;xmltag.org&quot; &gt;InMode Ltd.&lt;/span&gt; &lt;/b&gt;(Nasdaq: INMD)&lt;b&gt; (&quot;&lt;span value=&quot;NASDAQ-NMS:INMD&quot; idsrc=&quot;xmltag.org&quot; &gt;InMode&lt;/span&gt;&quot;)&lt;/b&gt;, a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter of 2026.&lt;/p&gt;
&lt;div id=&quot;prni_dvprnejpg59aeleft&quot; dir=&quot;ltr&quot; style=&quot;width: 100%; text-align: left;&quot;&gt;&lt;img id=&quot;prnejpg59aeleft&quot; style=&quot;width: 400px; height: 223px;&quot; title=&quot;InMode Logo&quot; src=&quot;https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg&quot; alt=&quot;InMode Logo&quot; align=&quot;middle&quot; /&gt;&lt;/div&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;Second Quarter 2026 Highlights:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;Quarterly GAAP revenues of &lt;money&gt;$95.6 million&lt;/money&gt;, consistent with the second quarter of 2025.&lt;/li&gt;&lt;li&gt;Quarterly revenues from consumables and service of &lt;money&gt;$22.3 million&lt;/money&gt;, an increase of 13% compared to the second quarter of 2025.&lt;/li&gt;&lt;li&gt;GAAP operating income of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/InMode+Reports+Second+Quarter+2026+Financial+Results%3A+Quarterly+GAAP+Revenues+of+%2495.6+Million%2C+Consistent+with+the+Second+Quarter+of+2025/26869997.html</guid>
   <pubDate>Wed, 05 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.41658003</category>
   	  </item>
  <item>
   <title>Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One</title>
   <link>http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  04, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;American News Group&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox&lt;sup&gt;®&lt;/sup&gt; created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp;amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</guid>
   <pubDate>Tue, 04 Aug 2026 09:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	  </item>
  <item>
   <title>Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  04, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;American News Group&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox&lt;sup&gt;®&lt;/sup&gt; created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp;amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</guid>
   <pubDate>Tue, 04 Aug 2026 09:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	  </item>
  <item>
   <title>Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One</title>
   <link>http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  04, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;American News Group&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox&lt;sup&gt;®&lt;/sup&gt; created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp;amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</guid>
   <pubDate>Tue, 04 Aug 2026 09:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	  </item>
  <item>
   <title>Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  04, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;American News Group&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox&lt;sup&gt;®&lt;/sup&gt; created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp;amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</guid>
   <pubDate>Tue, 04 Aug 2026 09:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	  </item>
  <item>
   <title>Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One</title>
   <link>http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  04, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;American News Group&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox&lt;sup&gt;®&lt;/sup&gt; created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp;amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</guid>
   <pubDate>Tue, 04 Aug 2026 09:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	  </item>
  <item>
   <title>Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;NEW YORK, Aug.  04, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;American News Group&lt;/a&gt; &lt;strong&gt;News Commentary&lt;/strong&gt; - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox&lt;sup&gt;®&lt;/sup&gt; created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp;amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html</guid>
   <pubDate>Tue, 04 Aug 2026 09:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABBV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ANIK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
   	  </item>
 </channel>
</rss>
